Cargando…
Long-term colonisation with donor bacteriophages following successful faecal microbial transplantation
BACKGROUND: Faecal microbiota transplantation (FMT) is used in the treatment of recurrent Clostridium difficile infection. Its success is typically attributed to the restoration of a diverse microbiota. Viruses (including bacteriophages) are the most numerically dominant and potentially the most div...
Autores principales: | Draper, L. A., Ryan, F. J., Smith, M. K., Jalanka, J., Mattila, E., Arkkila, P. A., Ross, R. P., Satokari, R., Hill, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288847/ https://www.ncbi.nlm.nih.gov/pubmed/30526683 http://dx.doi.org/10.1186/s40168-018-0598-x |
Ejemplares similares
-
Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection
por: Jalanka, Jonna, et al.
Publicado: (2016) -
Minor Effect of Antibiotic Pre-treatment on the Engraftment of Donor Microbiota in Fecal Transplantation in Mice
por: Freitag, Tobias L., et al.
Publicado: (2019) -
Fecal Transplantation Treatment of Antibiotic-Induced, Noninfectious Colitis and Long-Term Microbiota Follow-Up
por: Satokari, Reetta, et al.
Publicado: (2014) -
Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial
por: Lahtinen, Perttu, et al.
Publicado: (2023) -
Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series
por: Lahtinen, Perttu, et al.
Publicado: (2017)